title: [Appropriate pharmacological therapy after surgical or percutaneous myocardial revascularization].
authors.affiliation: U.O. di Cardiologia, Spedali Civili, e Cattedra di Cardiologia, Università degli Studi, Brescia. faggiano@numerica.it
authors.forename: Pompilio
authors.initials: P
authors.lastname: Faggiano
authors.forename: Stefania
authors.initials: S
authors.lastname: De Feo
authors.forename: Silvia
authors.initials: S
authors.lastname: Frattini
authors.forename: Roberto
authors.initials: R
authors.lastname: Tramarin
authors.forename: Livio
authors.initials: L
authors.lastname: Dei Cas
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000628:therapy; D009204:Myocardial Revascularization / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors